Canada Greatly Expands Access to Abortion DrugBy Lianne Laurence
NRL News Today - November 7, 2017
The Canadian government is expanding access to the abortion pill, including allowing the drug for abortions of children in utero of up to nine weeks gestation, and allowing pharmacists to dispense it directly, rather than requiring doctors to do so.
Health Canada made its decision based on evidence submitted by the drug’s sponsor, Linepharma, according to an information update the department released Tuesday.
Linepharma is represented in Canada by Celopharma.
Health Canada says it also undertook a “thorough review of new and existing scientific literature on the safe use and effectiveness of Mifegymiso.”
It has authorized the following:
- Mifegymiso can now be prescribed up to nine weeks (63 days) into a pregnancy, rather than the previous limit of seven weeks (49 days).
- Mifegymiso can now be dispensed directly to patients by a pharmacist or a prescribing health professional.
- Health professionals are no longer required to complete an education program before they can prescribe Mifegymiso.
- The requirement for written patient consent to use Mifegymiso is being removed.
- Health professionals will no longer be required to register with Celopharma in order to prescribe or dispense Mifegymiso.
Subscribe to our monthly email, Life Light, for guidance from God's Word on life and family issues. Enjoy articles, Q&As, devotions and resources designed for you - delivered right to your inbox.
Would a friend, relative, or acquaintance find a particular page or article useful? Fill out the form below to send it to a friend!
Please fill out the small form below to leave a comment or suggestion about the page you were just visiting. Any and all feedback is appreciated! Your feedback will help make our website even better.